Eli Lilly and Company is a global, research-driven pharmaceutical firm renowned for developing innovative medicines and biologics across neuroscience, oncology, diabetes, immunology, and cardiometabolic disease. Built on a strong R&D culture, the company is notable for its robust clinical pipeline, advances in insulin and biologic therapies, and strategic partnerships that accelerate patient-focused drug development worldwide.